p. 125−130
1735-3688
Vol.31/No.3
p. 131−134
1735-3688
Vol.31/No.3
p. 135−138
1735-3688
Vol.31/No.3
p. 139−142
1735-3688
Vol.31/No.3
p. 143−146
1735-3688
Vol.31/No.3
p. 147−150
1735-3688
Vol.31/No.3
p. 151−155
1735-3688
Vol.31/No.3
p. 156−158
1735-3688
Vol.31/No.3
p. 159−164
1735-3688
Vol.31/No.3
p. 164−166
1735-3688
Vol.31/No.3
p. 167−169
1735-3688
Vol.31/No.3
13.2 g/dl and normal serum copper levels in their 13-18 weeks of gestation were randomized into case and control groups. From 20th week till the end of the pregnancy ferrous sulfate tablets (150 mg tablet, containing 50 mg elemental iron) were given to the case group whereas, the controls received daily placebo tablets. Hemoglobin and serum copper levels were measured during the weeks of 24 to 28 (first trimester) and 32 to 36 (second trimester). Serum copper level of the case group during the second and third trimester was significantly lower than of the control group. It is concluded that, iron supplementation in pregnant women with hemoglobin above 13.2 g/dl possibility increases the risk of copper deficiency. ]]>
p. 170−172
1735-3688
Vol.31/No.3
p. 173−175
1735-3688
Vol.31/No.3
p. 176−178
1735-3688
Vol.31/No.3
p. 179−179
1735-3688
Vol.31/No.3